From: Validation of a frailty index in older cancer patients with solid tumours
Assessments | N = 175 | FI median (IQR) | Effect Size | p value |
VES Assessment | ||||
Not vulnerable | 112 (64.0%) | 0.24 (0.19–0.29) | r = 0.67 | < 0.001 |
Vulnerable | 63 (36.0%) | 0.42 (0.36–0.52) | ||
Dr Assessment | ||||
Fit | 90 (53.3%) | 0.24 (0.19–0.32) | Reference | |
Vulnerable | 52 (30.8%) | 0.30 (0.22–0.43) | r = 0.29 | 0.001 |
Frail | 27 (16.0%) | 0.38 (0.29–0.61) | r = 0.43 | < 0.001 |
Treatment Decisions | N = 175 | FI median (IQR) | OR (95% CI) | |
Treatment plan | ||||
Completed | 46 (26.9%) | 0.24 (0.15–0.35) | 1.65 (1.32–2.05) | < 0.001 |
Terminated | 94 (55.0%) | 0.27 (0.21–0.36) | ||
Not planned | 31 (18.1%) | 0.40 (0.30–0.56) | ||
Drug alteration | ||||
< 10% | 87 (61.7%) | 0.27 (0.21–0.35) | 0.98 (0.71–1.28) | 0.89 |
≥ 10% | 54 (38.3%) | 0.26 (0.20–0.38) |